Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study

Overview of attention for article published in Maturitas, February 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 2,311 followers.

#Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study http://t.co/vRt6v9OAB8

#Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study http://t.co/qfdOHbDMyi

Prasterone has parallel beneficial effects on the main symptoms of #vulvovaginal atrophy: 52-week open-label study. http://t.co/gtNG6xypjx

#Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study http://t.co/d1CqBvLaHa

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.